Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease-Reference-Cited by-同舟云学术

Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease

Published:2019-03-04 Issue:5 Volume:15 Page:655-665
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Schindler Suzanne E.¹²,Li Yan³,Todd Kaitlin W.⁴,Herries Elizabeth M.¹²⁵,Henson Rachel L.¹²⁵,Gray Julia D.¹²⁵,Wang Guoqiao³,Graham Danielle L.⁶,Shaw Leslie M.⁷,Trojanowski John Q.⁷⁸,Hassenstab Jason J.¹²,Benzinger Tammie L.S.¹²⁹,Cruchaga Carlos²⁵¹⁰,Jucker Mathias¹¹¹²,Levin Johannes¹¹¹³,Chhatwal Jasmeer P.¹⁴,Noble James M.¹⁵,Ringman John M.¹⁶,Graff‐Radford Neill R.¹⁷,Holtzman David M.¹²⁵,Ladenson Jack H.⁵,Morris John C.¹²,Bateman Randall J.¹²⁵,Xiong Chengjie¹²³,Fagan Anne M.¹²⁵,

Affiliation:

1. Department of NeurologyWashington University School of MedicineSt. LouisMO

2. Knight Alzheimer's Disease Research CenterWashington University School of MedicineSt. LouisMO

3. Division of BiostatisticsWashington University School of MedicineSt. LouisMO

4. Department of Pathology and ImmunologyWashington University School of MedicineSt. LouisMO

5. Hope Center for Neurological DisordersWashington University School of MedicineSt. LouisMO

6. Biomarkers, Research and Early DevelopmentBiogenCambridgeMA

7. Department of Pathology and Laboratory MedicinePerelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPA

8. Center for Neurodegenerative Disease ResearchPerelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPA

9. Mallinckrodt Institute of RadiologyWashington University School of MedicineSt. LouisMO

10. Department of PsychiatryWashington University School of MedicineSt. LouisMO

11. German Center for Neurodegenerative Diseases (DZNE)

12. Hertie Institute for Clinical Brain ResearchUniversity of TübingenTübingen

13. Department of NeurologyLudwig Maximilians UniversityMunich

14. Department of NeurologyMassachusetts General HospitalHarvard Medical SchoolBostonMA

15. Department of NeurologyColumbia University Medical CenterNew York CityNY

16. Department of NeurologyKeck School of Medicine at the University of Southern CaliforniaLos AngelesCA

17. Department of NeurologyMayo ClinicJacksonvilleFL

Funder

Avid Radiopharmaceuticals

AbbVie

Biogen

Fujirebio US

CS Fund

National Institute on Aging

Japan Agency for Medical Research and Development

Lilly

C2N Diagnostics

Denali

Janssen Immunotherapy

Eli Lilly and Company

Pfizer

Fujirebio

Roche Diagnostics

German Center for Neurodegenerative Diseases

Raul Carrea Institute for Neurological Research

Research and Development

Korea Health Industry Development Institute

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2018.12.019

Reference50 articles.

1. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census

2. Neuron Number in the Entorhinal Cortex and CA1 in Preclinical Alzheimer Disease

3. Pathologic Correlates of Nondemented Aging, Mild Cognitive Impairment, and Early-Stage Alzheimer's Disease

4. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

5. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating White Matter Neuroinflammation in Alzheimer Disease Using Diffusion-Based Neuroinflammation Imaging;Neurology;2024-02

2. Inhibitory effects of β-asarone on lncRNA BACE1-mediated induction of autophagy in a model of Alzheimer’s disease;Behavioural Brain Research;2024-02

3. Monitoring synaptic pathology in Alzheimer’s disease through fluid and PET imaging biomarkers: a comprehensive review and future perspectives;Molecular Psychiatry;2024-01-16

4. Diagnostic Utility of Cerebrospinal Fluid Biomarkers in Patients with Rapidly Progressive Dementia;Annals of Neurology;2023-11-10

5. Beyond the amyloid cascade: An update of Alzheimer's disease pathophysiology;Revue Neurologique;2023-10